BIOKID: Randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]

BMC Nephrology

Volumn 5, Issue , 2004, Pages 1-6

  Nau, Barbara ^a   Schmitt, Claus P ^a   Almeida, Margarida ^b   Arbeiter, Klaus ^c   Ardissino, Gianluigi ^d   Bonzel, Klaus E ^e   Edefonti, Alberto ^d   Fischbach, Michel ^f   Haluany, Karin ^g   Misselwitz, Joachim ^h   Kemper, Markus J ⁱ   Rönnholm, Kai ^j   Wygoda, Simone ^g   Schaefer, Franz ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c UNIVERSITY OF VIENNA   (Austria)

^d PARKINSON INSTITUTE   (Italy)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^g Klinikum St Georg   (Germany)

^h JENA UNIVERSITY HOSPITAL   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^j UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; BUFFER; LACTIC ACID; PERITONEAL DIALYSIS FLUID; PHOSPHATE BINDING AGENT; BIOMATERIAL; CREATININE; DIALYSIS FLUID; LACTIC ACID DERIVATIVE;

ABDOMINAL WALL HERNIA; ACID BASE BALANCE; ACIDITY; ADULT; ALLERGIC REACTION; ARTICLE; BIOCOMPATIBILITY; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; DISEASE SEVERITY; EFFLUENT; EQUILIBRIUM DIALYSIS; HUMAN; INCIDENCE; INFANT; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAIN; PATIENT MONITORING; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PERITONITIS; PH MEASUREMENT; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; ADOLESCENT; ANGIOGENESIS; DRUG EFFECT; EPITHELIUM; METABOLISM; METHODOLOGY; PATHOLOGY; PERITONEUM; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; TRANSPORT AT THE CELLULAR LEVEL;

ADOLESCENT; BICARBONATES; BIOCOMPATIBLE MATERIALS; BIOLOGICAL TRANSPORT; BUFFERS; CHILD; CHILD, PRESCHOOL; CREATININE; DIALYSIS SOLUTIONS; EPITHELIUM; HUMANS; INFANT; LACTATES; NEOVASCULARIZATION, PHYSIOLOGIC; PERITONEAL DIALYSIS; PERITONEUM; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE;

EID: 9144237140     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-5-14     Document Type: Article

References (24)

1. Davies SJ, Phillips L, Griffiths SM, Russell LH, Naish PF, Russell GI: What really happens to people on long-term peritoneal dialysis? Kidney International 1998, 54:2207-2217.
2. Schaefer F, Klaus G, Müller-Wiefel DE, Mehls O, (MEPPS) Mid European Pediatric Peritoneal Dialysis Study Group: Current practice of peritoneal dialysis in children: results of a longitudinal survey. Perit Dial Int 1999, 19 Suppl.2:S445-S449.
3. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002, 13:470-479.
4. Schneble F, Bonzel KE, Waldherr R, Bachmann S, Roth H, Scharer K: Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis. Pediatr Nephrol 1992, 6:542-546.
5. Dobbie JW, Anderson JD, Hind C: Long term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int 1994, 14 Suppl S3:16-20.
6. Witowski J, Topley N, Jorres A, Liberek T, Coles GA, Williams JD: Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1995, 47:282-293.
7. Davies SJ, Phillips L, Naish PF, Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001, 12:1046-1051.
8. Krediet RT, Lindholm B, Rippe B: Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000, 20:S22-42.
9. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, Aguilera A, Sanchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sanchez-Madrid F, Lopez-Cabrera M: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003, 348:401-413.
10. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jorres A: Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001, 12:2434-2441.
11. Inagi R, Miyata T, Yamamoto T, Suzuki D, Urakami K, Saito A, van Ypersele de Strihou C, Kurokawa K: Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 1999, 463:260-264.
12. Kang DH, Hong YS, Lim HJ, Choi JH, Han DS, Yoon KI: High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-betal of human peritoneal mesothelial cells: effect of cytokine costimulation. Perit Dial Int 1999, 19:221-230.
13. Haas S, Schmitt CP, Bonzel KE, Pieper AK, Fischbach M, John U, Arbeiter K, Schaup TP, Passlick-Deetjen J, Mehls O, Schaefer F: Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephrol 2003, 14:2632-2638.
14. Jones S, Holmes CJ, Krediet RT, Mackenzie R, Faict D, Tranaeus A, Williams JD, Coles GA, Topley N: Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 2001, 59:1529-1538.
15. Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, Stelin G, Weiss J, Nielsen FD, Bro S, Friedberg M, Wieslander A: Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001, 59:348-357.
16. Wang T, Cheng HH, Liu SM, Wang Y, Wu JL, Peng WX, Zhong JH, Lindholm B: Increased peritoneal membrane permeability is associated with abnormal peritoneal surface layer. Perit Dial Int 2001, 21 Suppl 3:S345-348.
17. Schmitt CP, Haraldsson B, Doetschmann R, Zimmering M, Greiner C, Böswald M, Klaus G, Passlick-Deetjen J, Schaefer F: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children. Kidney Int 2002, 61:1527-1536.
18. Fischbach M, Terzic J, Chauvé S, Laugel V, Muller A, Haraldsson B: Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children. Nephrol Dial Transplant 2004, 19:925-932.
19. Fischbach M, Haraldsson B, Helms P, Danner S, Laugel V, Terzic J: The peritoneal membrane: a dynamic dialysis membrane in children. Adv Perit Dial 2003, 19:265-268.
20. Breborowicz A, Rodela H, Martis L, Oreopoulos DG: Intracellular glutathione in human peritoneal mesothelial cells exposed in vitro to dialysis fluid. Int J Artif Organs 1996, 19:268-275.
21. Liberek T, Topley N, Jorres A, Petersen MM, Coles GA, Gahl GM, Williams JD: Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993, 65(2):260-265.
22. Plum J, Rezeghi P, Lordnejad RM, Perniok A, Fleisch M, Fussholler A, Schneider M, Grabensee B: Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffereffects on human mesothelial cells. Am J Kidney Dis 2001, 38:867-875.
23. Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH: Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 2002, 13:480-489.
24. Warady BA, Schaefer F, Holloway M, Alexander S, Kandert M, Piraino B, Salusky I, Tranaeus A, Divino J, Honda M, Mujais S, Verrina E: Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int 2000, 20:610-624.